ARTICLE | Company News
CuraGen subsidiary names CEO
August 1, 2000 7:00 AM UTC
Drug discovery play CRGN hired M. Scott Salka as president and CEO of its 454 Corp. subsidiary (Branford, Conn.), which is developing genomic and proteomic technologies. Formerly, Salka was president ...